| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca0841c52dc980c3f201762d410f79b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
| filingDate |
2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e6eefdb8ebf75dc4e74e01d466bb7a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea2eac68c4cda11abe43928774aaa28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20adc1a381da57079e57729934b9c64e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e0beceb144d45e32108f043a9d1cb1b |
| publicationDate |
2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022109227-A1 |
| titleOfInvention |
Combined cancer therapy of b7-h3 and cd47 immune checkpoint inhbitior and methods of use |
| abstract |
The present disclosure generally relates to compositions and methods for treating a solid tumor in a subject, wherein administering compositions having a combination of an inhibitor of B7-H3 (CD276) and an inhibitor of CD47-SIRPĪ± can inflame a cold tumor microenvironment. |
| priorityDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |